X0306 4 2015-11-02 0 0001610092 Diplomat Pharmacy, Inc. DPLO 0001618898 Kadlec Gary W 4100 S. SAGINAW STREET FLINT MI 48507 1 1 0 0 President Common Stock 2015-11-02 4 M 0 30000 4.28 A 30000 D Common Stock 2015-11-02 4 S 0 30000 28.0313 D 0 D Employee Stock Option to Acquire Common Stock 4.28 2015-11-02 4 M 0 30000 0 D 2022-09-01 Common Stock 30000 212682 D The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on June 24, 2015. The plan provides for monthly sales of 30,000 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 30,000 shares remain available for sale under the plan, which is set to expire on December 31, 2015. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $28.00 to $28.07 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The options were granted on September 1, 2012. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 75% of the options originally granted are currently vested and exercisable. The total number of securities reported in this column have been adjusted from a previously reported transaction which included 8,024 shares that were performance based awards with the same exercise price and expiration date as the time based options reflected on the Form 4 relating to such transaction. Jeffrey H. Kuras, Attorney-in-fact 2015-11-04